Medacta Group SA
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	CHF363.12M N/A	CHF437.12M 20.37%	CHF510.77M 16.85%	Avg: CHF640.95M Low: CHF640.95M High: CHF640.95M avg. 25.48%	Avg: CHF707.41M Low: CHF707.41M High: CHF707.41M avg. 10.36%	Avg: CHF802.58M Low: CHF802.58M High: CHF802.58M avg. 13.45%
Net Income % change YoY	CHF51.52M N/A	CHF46.24M -10.23%	CHF47.36M 2.40%	Avg: CHF87.77M Low: CHF87.77M High: CHF87.77M avg. 85.31%	Avg: CHF106.26M Low: CHF106.26M High: CHF106.26M avg. 21.07%	Avg: CHF124.67M Low: CHF124.67M High: CHF124.67M avg. 17.31%
EBITDA % change YoY	CHF97.81M N/A	CHF106.95M 9.34%	CHF119.64M 11.86%	Avg: CHF158.62M Low: CHF158.62M High: CHF158.62M avg. 32.58%	Avg: CHF175.07M Low: CHF175.07M High: CHF175.07M avg. 10.36%	Avg: CHF198.62M Low: CHF198.62M High: CHF198.62M avg. 13.45%
EPS % change YoY	$2.58 N/A	$2.32 -10.07%	$2.37 2.15%	Avg: $4.39 Low: $4.39 High: $4.39 avg. 85.24%	Avg: $5.32 Low: $5.32 High: $5.32 avg. 21.07%	Avg: $6.24 Low: $6.24 High: $6.24 avg. 17.31%
Operating Expenses % change YoY	CHF202.68M N/A	CHF247.14M 21.93%	CHF273.40M 10.62%	Avg: CHF319.19M Low: CHF319.19M High: CHF319.19M avg. 16.74%	Avg: CHF352.28M Low: CHF352.28M High: CHF352.28M avg. 10.36%	Avg: CHF399.68M Low: CHF399.68M High: CHF399.68M avg. 13.45%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 41.23% in 2025-2027.

We have gathered data from N/A analysts. Their low estimate is 87.77M, average is 87.77M and high is 87.77M.

Wall Street analysts forecast annual average revenue growth of 16.43% in 2025-2027.

We have gathered data from N/A analysts. Their low revenue estimate is CHF640.95M, average is CHF640.95M and high is CHF640.95M.

Wall Street analysts forecast annual average earnings growth of 41.21% in 2025-2027.

We have gathered data from N/A analysts. Their low earnings per share estimate is $4.39, average is $4.39 and high is CHF4.39.